Samsara BioCapital »

Alamar Biosciences shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Alamar Biosciences shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Alamar Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Alamar Biosciences held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alamar Biosciences by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2026-06-30 $67M 2.5M 27.09

More positions owned by Samsara BioCapital

Scholar Rock Hldg Corp (SRRK)
Alumis (ALMS)
Mineralys Therapeutics (MLYS)
Septerna (SEPN)
Alamar Biosciences Common Stock
Neurogene (NGNE)
Kalaris Therapeutics (KLRS)
Spyglass Pharma Com Shs (SGP)
Sutro Biopharma Com Shs (STRO)
Inventiva Sa Ads (IVA)
Jade Biosciences Com New (JBIO)
Parabilis Medicines
Vtv Therapeutics Cl A New (VTVT)
Aquestive Therapeutics (AQST)
Nkarta (NKTX)

View all positions for Samsara BioCapital

Top funds holding Alamar Biosciences

Samsara BioCapital
Braidwell
Alliancebernstein
Hillhouse Capital Advisors
Emerald Advisers
Artisan Partners Limited Partnership
Vanguard Capital Management
Emerald Mutual Fund Advisers, Trust
New York State Common Retirement Fund
Citadel Advisors
Goldman Sachs Group
Avidity Partners Management
Burkehill Global Management
Jpmorgan Chase & Co
Vanguard Portfolio Management

View all funds holding Alamar Biosciences